CAS 926906-64-1

5-[4-(4-Bromoanilino)anilino]-N'-(1-hydroxypropan-2-yl)-3-oxo-1,2-thiazole-4-carboximidamide

CAS: 926906-64-1

5-[4-(4-Bromoanilino)anilino]-N'-(1-hydroxypropan-2-yl)-3-oxo-1,2-thiazole-4-carboximidamide is a potent inhibitor of the human Fc receptor (FcR). The Fc receptor plays a key role in immunoregulation. It is also a pharmacological target for drugs that modulate immune responses. 5-[4-(4-Bromoanilino)anilino]-N'-(1-hydroxypropan-2-yl)-3-oxo-1,2-thiazole-4-carboximidamide has been shown to inhibit the binding of an antibody with its antigen and to inhibit the binding of an antibody with its antigen. This inhibition was dose dependent and reversible. The IC50 value for 5-[4-(4-Bromoanilino)anilino]-N'-

Formel: C₁₉H₂₀BrN₅O₂S

Reinheit: Min. 95%

Molekulargewicht: 462.4 g/mol

Ref: 3D-BMB90664

VRX-0466617

CAS: 926906-64-1

VRX-0466617 is a novel selective Chk2 inhibitor.

Formel: C₁₉H₂₀BrN₅O₂S

Farbe und Form: Solid

Molekulargewicht: 462.36

Ref: TM-T29116